跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister pack
Approved
STANDARD
LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
21ed6648dbd2db42
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
21ed6648dbd2db42
Product Name
LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister pack
Artg Id
377103
Artg Name
LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2022-08-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e25d8950b92d8807a5a988e401512d37.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f73c60845e161aeca23a19a8cd3a6f49.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
21ed6648dbd2db42
Type
Standard
Back to TGA Approvals